In patients with elevated cardiovascular risk, higher pro-inflammatory adipocytokine levels are observed in EAT than subcutaneous adipose tissue (SAT) (2), and the EAT of patients with severe coronary artery disease (CAD) expresses less adiponectin (3). This evidence concerns the gene ADIPOQ and coronary artery disorder.